Anticoagulants Market| Aspen Holdings, Bayer AG, Boehringer Ingelheim GmbH, Pfizer, Inc., Sanofi S.A

A Comprehensive research study conducted by KD Market Insights on " Anticoagulants Market by Drug Class (NOACs, Heparin & LMWH, Vitamin K Antagonist, and Others), Route of Administration (Oral Anticoagulant and Injectable Anticoagulant), and Application (Atrial Fibrillation & Heart Attack, Stroke, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), and Others) - Global Opportunity Analysis and Industry Forecast, 2018-2025" report offers extensive and highly detailed historical, current and future market trends in the global and regional/market. The Anticoagulants Market report includes market size, growth drivers, barriers, opportunities, trends and other information which helps to find new opportunities in this market for the growth of the business through new technologies and developments.

The global anticoagulants market was valued at $24,265 million in 2017, and is expected to reach $43,427 million by 2025, growing at a CAGR of 7.5% from 2018 to 2025. Anticoagulants, commonly known as blood thinners, are chemical substances that prevent or reduce coagulation of blood and prolong the clotting time. The market has different types of anticoagulant drugs, and each drug works by inhibiting various pathways of blood coagulation. These drugs are majorly used for high risk of blood clots, such as atrial fibrillation, deep vein thrombosis, myocardial infarction, pulmonary embolism, stroke, and others.

Request for Sample@ https://www.kdmarketinsights.com/sample/4187

The global anticoagulants market is expected to grow at a significant rate during the forecast period, owing to increasing prevalence of venous thromboembolism (VTE) and cardiovascular disease across the world, growing adoption of novel oral anticoagulants (NOACs), and growing awareness of NOACs in developing regions. Furthermore, increasing obese and geriatric population and growing demand of novel therapeutics are anticipated to further influence the market growth during the forecast period. On the other side, higher price of NOACs and lack of antidots for NOACs impede the market growth.

The global anticoagulants market is segmented based on drug class, route of administration, application, and region. On the basis of drug class, the anticoagulants market is classified as NOACs, heparin & LMWH, vitamin K antagonist, and others. As per the route of administration, the market is segmented as oral anticoagulant and injectable anticoagulant. Application market-wise, it is classified as atrial fibrillation & heart attack, stroke, deep vein thrombosis (DVT), pulmonary embolism (PE), and others.

According to region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2017 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
A comprehensive analysis of all the geographical regions is provided to determine the existing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS
By drug class
- NOACs
- Eliquis
- Bevyxxa
- Xarelto
- Savaysa & lixiana
- Pradaxa
- Heparin & LMWH
- Vitamin K antagonist
- Others

By route of administration
- Oral anticoagulant
- Injectable anticoagulant

By application
- Atrial fibrillation & heart attack
- Stroke
- Deep vein thrombosis (DVT)
- Pulmonary embolism (PE)
- Others

By region
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT
- Aspen Holdings
- Bayer AG
- Boehringer Ingelheim GmbH
- Bristol-Myers Squibb Company
- Daiichi Sankyo Company, Limited
- GlaxoSmithKline plc.
- Johnson & Johnson (Janssen Pharmaceuticals, Inc.)
- Pfizer, Inc.
- Portola Pharmaceuticals, Inc.
- Sanofi S.A.

Browse Full Report with TOC @ https://www.kdmarketinsights.com/product/anticoagulants-market-amr

Table of Contents:

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.1.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top player positioning
3.3. Market Dynamics
3.3.1. Drivers
3.3.1.1. Increase in prevalence of atrial fibrillation, venous thromboembolism and stroke
3.3.1.2. Rise in number of geriatric population
3.3.1.3. Increase in prevalence of obesity
3.3.1.4. Surge in healthcare expenditures worldwide
3.3.2. Restraints
3.3.2.1. High price of NOACs
3.3.2.2. Poor demand in under developed countries
3.3.3. Opportunity
3.3.3.1. Increase in demand for NOACs
3.3.3.2. Growth opportunities in emerging markets
3.3.4. Impact Analyses

CHAPTER 4: ANTICOAGULANTS MARKET, BY DRUG CLASS
4.1. Overview
4.1.1. Market size and forecast
4.2. NOACs
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by type
4.2.2.1. Eliquis market size and forecast
4.2.2.2. Bevyxxa market size and forecast
4.2.2.3. Xarelto market size and forecast
4.2.2.4. Savaysa & Lixiana market size and forecast
4.2.2.5. Pradaxa market size and forecast
4.2.3. Market size and forecast, by region
4.2.4. Market analysis, by country
4.3. Heparins & LMWH
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Vitamin K Antagonists
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. Other Anticoagulant Drugs
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country

CHAPTER 5: ANTICOAGULANTS MARKET, BY ROUTE OF ADMINISTRATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Oral Anticoagulants
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Injectable Anticoagulants
5.3.1. Market size and forecast
5.3.2. Market analysis, by country

CHAPTER 6: ANTICOAGULANTS MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Atrial Fibrillation & Heart Attack
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Stroke
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.4. Deep Vein Thrombosis (DVT)
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
6.5. Pulmonary Embolism (PE)
6.5.1. Market size and forecast
6.5.2. Market analysis, by country
6.6. Others
6.6.1. Market size and forecast
6.6.2. Market analysis, by country
Continue…

Check for Discount @ https://www.kdmarketinsights.com/discount/4187

About Us:

KD Market Insights is one of the leading providers of market intelligence products and services. We offer reports on over 10+ industries and update our collection daily which helps our clients to access database of expert market insights on global industries, companies, products, and trends. Our in-house research experts have a wealth of knowledge in their respective domains. With KD Market Research, you always have the choice of getting customized report free of cost (up to 10%). Our support team will help you customize the report and scope as per your business needs. This ensures that you are making the right purchase decision.
Our clients list includes various Fortune 500 companies and leading advisory firms.

Contact Us:

KD Market Insights
90 State Street, Albany,
New York, USA 12207
+1 (518) 300-1215
Email: info@kdmarketinsights.com
Website: www.kdmarketinsights.com
Read More News: https://marketresearch531064260.wordpress.com/
https://consumergoods1234.blogspot.com/